This inventor holds 1 USPTO granted patent. Top assignee: Evotec (UK) Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Brearley: Innovator in SARM1 Inhibition
Introduction
Andrew Brearley is a notable inventor based in Chilton, GB. He has made significant contributions to the field of pharmacology, particularly in the development of inhibitors for SARM1. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Andrew Brearley holds a patent titled "Inhibitors of SARM1." This patent represents his innovative approach to targeting SARM1, which has implications for treating conditions related to neurodegeneration and inflammation. He has 1 patent to his name, showcasing his commitment to research and development in this area.
Career Highlights
Brearley is currently employed at Evotec (UK) Ltd, a company known for its cutting-edge research in drug discovery and development. His role at Evotec allows him to collaborate with other experts in the field and contribute to groundbreaking projects.
Collaborations
Some of his notable coworkers include Robert Owen Hughes and Rajesh Devraj. Their combined expertise enhances the innovative environment at Evotec, fostering advancements in therapeutic solutions.
Conclusion
Andrew Brearley exemplifies the spirit of innovation in the pharmaceutical industry. His work on SARM1 inhibitors is a testament to his dedication to improving health outcomes through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile